Stocks News

LAST PRICE
103.0600
TODAY'S CHANGE (%)
Trending Up3.9000 (3.9330%)

Bid / Lots
102.0000/ 1
Ask / Lots
165.3100/ 2
Open / Previous Close
99.9400 / 99.1600
Day Range
Low 96.9400
High 106.2400
52 Week Range
Low 43.5029
High 106.2400
Volume
846,034
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 8, 2024
- DJ Arcellx Is Maintained at Buy by HC Wainwright & Co., from 2:51PM ET on Friday Nov 08, 2024 by Dow Jones
  2:51PM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: ACLX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ACLX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 08, 2024 14:51 ET (19:51 GMT)
- DJ Arcellx Is Maintained at Overweight by Piper Sandler, from 8:32AM ET on Friday Nov 08, 2024 by Dow Jones
  8:32AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: ACLX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ACLX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 08, 2024 08:32 ET (13:32 GMT)
- DJ Arcellx Is Maintained at Buy by Needham, from 7:33AM ET on Friday Nov 08, 2024 by Dow Jones
  7:33AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: ACLX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ACLX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 08, 2024 07:33 ET (12:33 GMT)
Nov 7, 2024
- -- Earnings Flash (ACLX) ARCELLX Posts Q3 Revenue $26M, from 4:00PM ET on Thursday Nov 07, 2024 by MT Newswires
  4:00PM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: ACLX
  04:00 PM EST, 11/07/2024 (MT Newswires) -- ...
- Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights, from 4:00PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:00PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: ACLX
  
  As of September 30, 2024, Arcellx had cash, cash equivalents, and marketable securities of $676.7 million. Arcellx anticipates that its cash, cash equivalents, and marketable securities will fund its operations into 2027.

Nov 7, 2024
- Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Thursday Nov 07, 2024 by PR Newswire
  4:05PM ET on Thursday Nov 07, 2024 by PR Newswire
  Companies Mentioned: RNA
- Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: RNA
- *DJ Avidity Biosciences 3Q Loss/Shr 65c >RNA, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: RNA
Nov 6, 2024
- Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference, from 7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: KRYS
Nov 5, 2024
- DJ Krystal Biotech Is Maintained at Neutral by Citigroup, from 9:59AM ET on Tuesday Nov 05, 2024 by Dow Jones
  9:59AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: KRYS
- DJ Krystal Biotech Price Target Maintained With a $221.00/Share by HC Wainwright & Co., from 9:49AM ET on Tuesday Nov 05, 2024 by Dow Jones
  9:49AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: KRYS
Nov 4, 2024
- Krystal Biotech's Q3 Net Income Falls, Revenue Rises, from 8:34AM ET on Monday Nov 04, 2024 by MT Newswires
  8:34AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: KRYS
- -- Earnings Flash (KRYS) KRYSTAL BIOTECH Reports Q3 Revenue $83.8M, from 8:01AM ET on Monday Nov 04, 2024 by MT Newswires
  8:01AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: KRYS
- Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: KRYS
- Press Release: Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: KRYS

Arcellx Inc
NASDAQ:ACLXUnited States

Search Criteria

Nov 8, 2024

DJ Arcellx Is Maintained at Buy by HC Wainwright & Co., from 2:51PM ET on Friday Nov 08, 2024 by Dow Jones

DJ Arcellx Is Maintained at Overweight by Piper Sandler, from 8:32AM ET on Friday Nov 08, 2024 by Dow Jones

DJ Arcellx Is Maintained at Buy by Needham, from 7:33AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

-- Earnings Flash (ACLX) ARCELLX Posts Q3 Revenue $26M, from 4:00PM ET on Thursday Nov 07, 2024 by MT Newswires

Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights, from 4:00PM ET on Thursday Nov 07, 2024 by Dow Jones

Peers Headlines

Nov 7, 2024

Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Thursday Nov 07, 2024 by PR Newswire

Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones

*DJ Avidity Biosciences 3Q Loss/Shr 65c >RNA, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 6, 2024

Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference, from 7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones

Nov 5, 2024

DJ Krystal Biotech Is Maintained at Neutral by Citigroup, from 9:59AM ET on Tuesday Nov 05, 2024 by Dow Jones

DJ Krystal Biotech Price Target Maintained With a $221.00/Share by HC Wainwright & Co., from 9:49AM ET on Tuesday Nov 05, 2024 by Dow Jones

Nov 4, 2024

Krystal Biotech's Q3 Net Income Falls, Revenue Rises, from 8:34AM ET on Monday Nov 04, 2024 by MT Newswires

-- Earnings Flash (KRYS) KRYSTAL BIOTECH Reports Q3 Revenue $83.8M, from 8:01AM ET on Monday Nov 04, 2024 by MT Newswires

Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones

Press Release: Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones